PROVIDER PROFILE · NPI 1669477956

Almerindo PortfolioM.D.

OphthalmologyGlen Rock, NJI

MEDICARE UTILIZATION · PART B · 2024

Total beneficiaries

197

Unique beneficiaries

—

Total services

405

Distinct HCPCS

Medicare payment

$41K

Peer benchmark

Total Medicare services vs. 531 Ophthalmology providers in NJ — bottom quintile (cohort median 2,470).

PRESCRIBING · PART D · 2024

Total Rx claims

155

Beneficiaries

—

Total drug cost

$23K

Distinct drugs

Brand share

29.7%

Top prescribed drugs

Latanoprost56 claims

Dorzolamide Hcl/Timolol Maleat30 claims

Timolol Maleate21 claims

Travoprost17 claims

Netarsudil Mesylat/Latanoprost16 claims

QUALITY · MIPS · 2024

No data available for this provider in 2024.

INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024

Total received

$15

Payment records

By payment type

Food and Beverage$15

REFERRAL NETWORK

Where Almerindo Portfolio's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 6 inbound referrers · 0 outbound destinations.

Receives referrals from

Inbound — who sends patients here

Physician	Patients	Visits
THE VALLEY HOSPITAL INC.	49	103
NEW YORK EYE & EAR INFIRMARY	40	88
Laboratory Corporation Of America Holdings Clinical Laboratory · Raritan, NJ	38	61
SADDLE RIVER VALLEY SURGICAL CENTER LLC	36	142
Ameripath New York Llc Clinical Laboratory · White Plains, NY	11	13
Bioreference Health, Llc Clinical Laboratory · Elmwood Park, NJ	11	20

Refers patients to

Outbound — where patients go next

No outbound pairs above the suppression threshold.

Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.

CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore

OIG/SAM exclusion screening, sanctions history